Waltham, Mass.-based Thermo Fisher Scientific completes its purchase of Boulder, Colo.-based picoSpin, maker of the world’s 1st miniature nuclear magnetic resonance spectrometer.
Thermo Fisher Scientific Inc. (NYSE:TMO) has acquired Boulder, Colo.-based picoSpin for an undisclosed amount.
The Waltham, Mass.-based Thermo Fisher will fold picoSpin into its chemical analysis business as part of the Analytical Technologies business unit, according to a prepared release.
Company officials said the purchase of the nuclear magnetic resonance spectrometer maker will expand Thermo Fisher’s portfolio of spectroscopy solutions and its array of analytical tools available to undergraduate and graduate chemistry laboratories.
"Adding picoSpin’s unique product offerings to our existing capabilities in spectroscopy enables us to offer an even broader suite of chemical analysis," VP and general manager of Thermo Fisher's molecular spectroscopy John Sos said in prepared remarks. "Bringing NMR capabilities to new markets where its practicality has been limited represents significant value for our customers."
The picoSpin-45, which was introduced in 2010, is a shoebox-sized device, 70 times smaller than other devices designed to offer the capabilities of larger spectrometers, Thermo Fisher Scientific said.
Here's a look at some of the top funding stories for medical device companies this week.
FDA officials warn against the use of "laparoscopic power morcellation" for the removal of uterine...
Bio-artificial liver maker Vital Therapies takes its IPO even lower, now planning to open at $12 per...
California surgical devices maker Cardica details a public offering of common and preferred stock...